Your browser doesn't support javascript.
loading
Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma?
Challis, B G; Casey, R T; Simpson, H L; Gurnell, M.
Affiliation
  • Challis BG; Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK.
  • Casey RT; Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
  • Simpson HL; Wolfson Diabetes and Endocrine Clinic, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
  • Gurnell M; Department of Medical Genetics, National Institute for Health Research Biomedical Research Centre, Cambridge, UK.
Clin Endocrinol (Oxf) ; 86(2): 163-167, 2017 Feb.
Article in En | MEDLINE | ID: mdl-27696513
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Paraganglioma / Pheochromocytoma / Preoperative Care Limits: Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2017 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Paraganglioma / Pheochromocytoma / Preoperative Care Limits: Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2017 Type: Article Affiliation country: United kingdom